A study of interval breast cancer within the NHS breast screening programme

被引:45
作者
Cowan, WK
Angus, B [1 ]
Gray, JC
Lunt, LG
Al-Tamimi, SR
机构
[1] Royal Victoria Infirm, Dept Pathol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[2] Queen Elizabeth Hosp, Breast Unit, Gateshead NE9 6SX, England
[3] Univ Teesside, Ctr Hlth & Med Res, Middlesbrough TS1 3BA, Cleveland, England
关键词
breast cancer screening; interval cancer;
D O I
10.1136/jcp.53.2.140
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim-To define the biological nature and malignant potential of interval cancers presenting to a breast unit within the NHS breast screening programme. Methods-112 interval cancers were compared with matched, screen detected and symptomatic cancers in terms of their radiographic, histopathological, and immunohistochemical features. Results-Interval cancers, strictly defined, showed no characteristic radiographic pattern. In terms of size, vascular invasion, lymph node status, and prognosis they were intermediate between screen detected and symptomatic cancers. Within the interval cancers there was an excess of grade 1 and grade 3 tumours, and lesions with a high Ki67 index but immunohistochemistry otherwise failed to discriminate between the three groups. Inclusion of data from false negative "intenal cancers" did not significantly alter the results. Conclusions-Interval cancers are more aggressive than screen detected cancers but in general less aggressive than symptomatic cancers. However, within a heterogeneous group, occasional interval cancers are exceptionally malignant.
引用
收藏
页码:140 / 146
页数:7
相关论文
共 45 条
[1]   Expression of metastasis-associated genes h-mtsl (S100A4) and nm23 in carcinoma of breast is related to disease progression [J].
Albertazzi, E ;
Cajone, F ;
Leone, BE ;
Naguib, RNG ;
Lakshmi, MS ;
Sherbet, GV .
DNA AND CELL BIOLOGY, 1998, 17 (04) :335-342
[2]   COMPARATIVE PATHOLOGY OF BREAST-CANCER IN A RANDOMIZED TRIAL OF SCREENING [J].
ANDERSON, TJ ;
LAMB, J ;
DONNAN, P ;
ALEXANDER, FE ;
HUGGINS, A ;
MUIR, BB ;
KIRKPATRICK, AE ;
CHETTY, U ;
HEPBURN, W ;
SMITH, A ;
PRESCOTT, RJ ;
FORREST, P .
BRITISH JOURNAL OF CANCER, 1991, 64 (01) :108-113
[3]   MAMMOGRAPHIC SCREENING AND MORTALITY FROM BREAST-CANCER - THE MALMO MAMMOGRAPHIC SCREENING TRIAL [J].
ANDERSSON, I ;
ASPERGREN, K ;
JANZON, L ;
LANDBERG, T ;
LINDHOLM, K ;
LINELL, F ;
LJUNGBERG, O ;
RANSTAM, J ;
SIGFUSSON, B .
BRITISH MEDICAL JOURNAL, 1988, 297 (6654) :943-948
[4]  
BOSARI S, 1995, VIRCHOWS ARCH, V427, P229
[5]  
Brekelmans CT, 1996, CANCER, V78, P1220, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1220::AID-CNCR8>3.0.CO
[6]  
2-D
[7]   SURVIVAL IN INTERVAL BREAST-CANCER IN THE DOM SCREENING-PROGRAM [J].
BREKELMANS, CT ;
PEETERS, PH ;
DEURENBERG, JJ ;
COLLETTE, HJ .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (11) :1830-1835
[8]   INTERVAL BREAST CANCERS IN THE SCREENING MAMMOGRAPHY PROGRAM OF BRITISH-COLUMBIA - ANALYSIS AND CLASSIFICATION [J].
BURHENNE, HJ ;
BURHENNE, LW ;
GOLDBERG, F ;
HISLOP, TG ;
WORTH, AJ ;
REBBECK, PM ;
KAN, L .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1994, 162 (05) :1067-1071
[9]   Screening interval breast cancers: Mammographic features and prognostic factors [J].
Burrell, HC ;
Sibbering, DM ;
Wilson, ARM ;
Pinder, SE ;
Evans, AJ ;
Yeoman, LJ ;
Elston, CW ;
Ellis, IO ;
Blamey, RW ;
Robertson, JFR .
RADIOLOGY, 1996, 199 (03) :811-817
[10]  
CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO